These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23954113)

  • 1. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization versus carriage of Clostridium difficile.
    Donskey CJ; Kundrapu S; Deshpande A
    Infect Dis Clin North Am; 2015 Mar; 29(1):13-28. PubMed ID: 25595843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of Clostridium difficile colonization.
    Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile.
    Bauer MP; Farid A; Bakker M; Hoek RA; Kuijper EJ; van Dissel JT
    Clin Microbiol Infect; 2014 Jul; 20(7):O446-9. PubMed ID: 24286342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.
    Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and Isolation of Clostridium difficile Asymptomatic Carriers During Clostridium difficile Infection Outbreaks: An Exploratory Study.
    Paquet-Bolduc B; Gervais P; Roussy JF; Trottier S; Oughton M; Brukner I; Longtin J; Loo VG; Dascal A; Longtin Y
    Clin Infect Dis; 2018 Nov; 67(11):1781-1783. PubMed ID: 29771298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients.
    Chen Y; Gu H; Lv T; Yan D; Xu Q; Gu S; Shen P; Quan J; Fang Y; Chen L; Ye G; Li L
    Epidemiol Infect; 2019 Jan; 147():e166. PubMed ID: 31063095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains.
    Rousseau C; Poilane I; De Pontual L; Maherault AC; Le Monnier A; Collignon A
    Clin Infect Dis; 2012 Nov; 55(9):1209-15. PubMed ID: 22843784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction.
    Mutters R; Nonnenmacher C; Susin C; Albrecht U; Kropatsch R; Schumacher S
    J Hosp Infect; 2009 Jan; 71(1):43-8. PubMed ID: 19041162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
    Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
    Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary investigation of environmental prevalence of Clostridium difficile affecting inpatients in a north Indian hospital.
    Vaishnavi C; Singh M
    Indian J Med Microbiol; 2012; 30(1):89-92. PubMed ID: 22361768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients.
    Blixt T; Gradel KO; Homann C; Seidelin JB; Schønning K; Lester A; Houlind J; Stangerup M; Gottlieb M; Knudsen JD
    Gastroenterology; 2017 Apr; 152(5):1031-1041.e2. PubMed ID: 28063955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.